Delgado et al., 2013 - Google Patents
Natural products as platforms for the design of sphingolipid-related anticancer agentsDelgado et al., 2013
- Document ID
- 8764276638138781580
- Author
- Delgado A
- Fabriàs G
- Casas J
- Abad J
- Publication year
- Publication venue
- Advances in cancer research
External Links
Snippet
Modulation of sphingolipid metabolism is a promising strategy for cancer therapy that has already opened innovative approaches for the development of pharmacological tools and rationally designed new drugs. On the other hand, natural products represent a classical …
- 239000005445 natural product 0 title abstract description 44
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
- C07F9/02—Phosphorus compounds
- C07F9/06—Phosphorus compounds without P-C bonds
- C07F9/08—Esters of oxyacids of phosphorus
- C07F9/09—Esters of phosphoric acids
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Delgado et al. | Natural products as platforms for the design of sphingolipid-related anticancer agents | |
| Pruett et al. | Thematic Review Series: Sphingolipids. Biodiversity of sphingoid bases (“sphingosines”) and related amino alcohols | |
| Chalfant et al. | The structural requirements for ceramide activation of serine-threonine protein phosphatases | |
| Fujita et al. | Potent immunosuppressants, 2-alkyl-2-aminopropane-1, 3-diols | |
| Liu et al. | A review of ceramide analogs as potential anticancer agents | |
| Lahiri et al. | The metabolism and function of sphingolipids and glycosphingolipids | |
| Pitman et al. | Inhibitors of the sphingosine kinase pathway as potential therapeutics | |
| Usta et al. | Structural requirements of ceramide and sphingosine based inhibitors of mitochondrial ceramidase | |
| Futerman | Sphingolipids | |
| El Bawab et al. | Ceramidases in the regulation of ceramide levels and function | |
| Canals et al. | Novel chemotherapeutic drugs in sphingolipid cancer research | |
| Hirata et al. | Structural determination of glucosylceramides in the distillation remnants of shochu, the Japanese traditional liquor, and its production by Aspergillus kawachii | |
| Prinetti et al. | Lack of ceramide generation and altered sphingolipid composition are associated with drug resistance in human ovarian carcinoma cells | |
| Padrón | Sphingolipids in anticancer therapy | |
| Grijalvo et al. | Design, synthesis and activity as acid ceramidase inhibitors of 2-oxooctanoyl and N-oleoylethanolamine analogues | |
| Azuma et al. | Total syntheses of symbioramide derivatives from L-Serine and their antileukemic activities | |
| WO2001079152A1 (en) | Sphingolipids | |
| Pyne | Cellular signaling by sphingosine and sphingosine 1-phosphate: their opposing roles in apoptosis | |
| Proksch et al. | Potent Inhibition of Acid Ceramidase by Novel B‐13 Analogues | |
| Kolter et al. | Inhibitors of glycosphingolipid biosythesis | |
| Dragusin et al. | Metabolism of the unnatural anticancer lipid safingol, L-threo-dihydrosphingosine, in cultured cells | |
| Merrill Jr et al. | Bioactive properties of sphingosine and structurally related compounds | |
| EP1430019A1 (en) | Sphingolipids | |
| RADIN et al. | Use of PDMP for the study of glycosphingolipid functions | |
| EP1354870A1 (en) | Dihydroceramide desaturase inhibitors. |